首页> 外文期刊>Bulletin du Cancer: Journal de l'Association Francaise pour l'Etude du Cancer >Lymph node metastases from squamous cell carcinoma of unknown primary site. Is it time to change of paradigm? [Les adénopathies métastatiques d'un carcinome épidermo?de sans porte d'entrée. Quelle est l'attitude actuelle?]
【24h】

Lymph node metastases from squamous cell carcinoma of unknown primary site. Is it time to change of paradigm? [Les adénopathies métastatiques d'un carcinome épidermo?de sans porte d'entrée. Quelle est l'attitude actuelle?]

机译:来自未知原发部位的鳞状细胞癌的淋巴结转移。现在该改变范式了吗? [非门鳞状细胞癌转移性淋巴结病。目前的态度是什么?]

获取原文
获取原文并翻译 | 示例
       

摘要

The diagnosis of carcinoma of unknown primary (CUP) is made after exclusion of the presence of a mucosal primary. There are two mains options for the primary treatment of CUP, either a neck node dissection followed by postoperative radiotherapy or chemo-radiotherapy, or a primary radiotherapy or chemoradiotherapy depending on the nodal stage followed in case of residual neck disease by a selective neck dissection. There is no data to suggest the superiority of one over the other. For radiotherapy, unilateral neck or bilateral neck, including the upper aerodigestive tract mucosa are possible options. There is no definite data to demonstrate the superiority of one over the other, but owing the reduced toxicity of unilateral irradiation, and the possibility of salvage treatment in case of emergence of a mucosal primary and/or a contralateral neck node development, the former may be the preferred option. Advances in radiotherapy such as intensity modulated radiation therapy have the potential to spare organs at risk and reduce late toxicity rates. A selective irradiation approach customized on "major" criteria, such as nodal stage and level, HPV and EBV status and accessory criteria, such as histological variants, is under investigation.
机译:排除原发性粘膜癌后,诊断为未知原发癌(CUP)。 CUP的主要治疗方法有两种主要选择,一种是颈部淋巴结清扫,然后进行术后放疗或化学放疗,另一种是根据淋巴结分期进行的主要放疗或放化疗,如果是残留的颈部疾病,则通过选择性的颈部清扫。没有数据表明一个人优于另一个人。对于放射治疗,可能选择单侧颈部或双侧颈部,包括上消化道粘膜。没有确定的数据可以证明一种药物相对于另一种药物的优越性,但是由于单侧照射的毒性降低,并且在出现粘膜原发和/或对侧颈淋巴结肿大的情况下有可能进行抢救治疗,因此前者可能是首选。诸如强度调制放射疗法之类的放射疗法的进展有可能使处于危险中的器官免受伤害,并降低后期毒性率。正在研究根据“主要”标准(例如淋巴结阶段和水平,HPV和EBV状态)以及辅助标准(例如组织学变异)定制的选择性照射方法。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号